Literature DB >> 18465376

Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.

Kara Savilla1, Lisa Kettler, Cherrie Galletly.   

Abstract

OBJECTIVE: Schizophrenia is a complex disorder characterized by impairment in a number of domains, all of which contribute to disability. The aim of the present study was to investigate the relationships between cognitive function, symptoms and quality of life (QOL) in schizophrenia.
METHOD: This cross-sectional study measured cognition, positive and negative symptom severity, and quality of life (measured with the Quality of Life Scale) in 57 outpatients with schizophrenia. Correlations between the different measures were sought. Multiple regression analyses were used to develop models of the contributions of cognitive deficits and symptomatology to QOL.
RESULTS: More severe positive and negative symptoms and cognitive impairment each correlated with poorer QOL. There was a moderate association between negative symptoms and cognition and a small association between positive symptoms and cognition. Age, gender, and drug and alcohol abuse did not significantly predict QOL. In the multiple regression analysis, entering the total cognition and total symptom scores produced a model that accounted for an additional 57% of the variance in QOL.
CONCLUSIONS: Improving quality of life for people with schizophrenia requires that positive and negative symptoms and cognition are each addressed as separate domains of impairment. But, given that these account for only 57% of the variance in QOL, other factors such as unemployment, poverty, social isolation and stigma may also be important.

Entities:  

Mesh:

Year:  2008        PMID: 18465376     DOI: 10.1080/00048670802050512

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  22 in total

1.  Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation.

Authors:  Arielle W Tolman; Matthew M Kurtz
Journal:  Schizophr Bull       Date:  2010-07-11       Impact factor: 9.306

2.  Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.

Authors:  Pudtan Phanthunane; Theo Vos; Harvey Whiteford; Melanie Bertram
Journal:  Cost Eff Resour Alloc       Date:  2011-05-13

3.  Functional outcome and service engagement in major depressive disorder with psychotic features: comparisons with schizophrenia, schizoaffective disorder and bipolar disorder in a 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).

Authors:  Tara Kingston; Paul J Scully; David J Browne; Patrizia A Baldwin; Anthony Kinsella; Eadbhard O'Callaghan; Vincent Russell; John L Waddington
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

Review 4.  Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.

Authors:  Joshua T Kantrowitz; Daniel C Javitt
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-10

5.  Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?

Authors:  Sofia Brissos; Vicent Balanzá-Martinez; Vasco Videira Dias; Ana Isabel Carita; Maria Luisa Figueira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-08       Impact factor: 5.270

6.  Performance-based empathy mediates the influence of working memory on social competence in schizophrenia.

Authors:  Matthew J Smith; William P Horan; Derin J Cobia; Tatiana M Karpouzian; Jaclyn M Fox; James L Reilly; Hans C Breiter
Journal:  Schizophr Bull       Date:  2013-06-14       Impact factor: 9.306

7.  Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

Authors:  Pamela DeRosse; George C Nitzburg; Melanie Blair; Anil K Malhotra
Journal:  Schizophr Res       Date:  2017-10-19       Impact factor: 4.939

8.  Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis.

Authors:  Timothy Tanzer; Shelukumar Shah; Catherine Benson; Veronica De Monte; Victoria Gore-Jones; Susan L Rossell; Frances Dark; Steve Kisely; Dan Siskind; Catarina Drumonde Melo
Journal:  Psychopharmacology (Berl)       Date:  2019-12-03       Impact factor: 4.530

Review 9.  Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Meenakshi Dauwan; Marieke J H Begemann; Sophie M Heringa; Iris E Sommer
Journal:  Schizophr Bull       Date:  2015-11-07       Impact factor: 9.306

10.  Outcome prediction with a social cognitive battery: a multicenter longitudinal study.

Authors:  Eric Brunet-Gouet; Capucine Decaix-Tisserand; Mathieu Urbach; Nadine Bazin; Bruno Aouizerate; Lore Brunel; Delphine Capdevielle; Isabelle Chereau; Caroline Dubertret; Julien Dubreucq; Guillaume Fond; Christophe Lançon; Sylvain Leignier; Jasmina Mallet; David Misdrahi; Sylvie Pires; Priscille Schneider; Franck Schurhoff; Hanan Yazbek; Anna Zinetti-Bertschy; Christine Passerieux; Paul Roux
Journal:  NPJ Schizophr       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.